sitem-insel AG

Rethinking Drug Design with Artificial Intelligence - Prof. Dr. Gisbert Schneider, ETH Zürich

Prof. Dr. Gisbert Schneider, MD

Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich

12:15 - 13:00

Prof. Schneider’s research activities focus on the development and application of adaptive intelligent systems for molecular de novo design and drug discovery, www.modlab.ethz.ch